Related Experiment Video

Updated: Aug 16, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

New gene and cell-based therapies for lung cancer

R K Batra1, S Sharma, S M Dubinett

  • 1Division of Pulmonary and Critical Care Medicine, GLA-VAHCS, UCLA School of Medicine, Jonsson Comprehensive Cancer Center, 90073, USA. rbatra@ucla.edu

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed

Insights

Lung cancer remains a leading cause of death due to limited treatments. Understanding the molecular defects driving lung cancer progression is key to developing targeted gene and cell therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is the primary cause of cancer mortality in the US.
  • Current treatment options for lung cancer are insufficient.
  • Molecular and cellular defects drive lung cancer development and progression.

Purpose of the Study:

  • To review fundamental defects in lung cancer pathogenesis.
  • To explore how understanding these defects informs new therapies.
  • To highlight the development of rational gene-based and cell-based treatments.

Main Methods:

  • Literature review of basic defects in lung cancer.
  • Analysis of molecular and cellular pathogenesis.
  • Examination of the link between fundamental defects and therapeutic strategies.

Main Results:

  • Identified key molecular and cellular defects in lung cancer.
  • Demonstrated how understanding these defects leads to targeted therapies.
  • Highlighted the potential of gene and cell-based treatments.

Conclusions:

  • Targeting specific molecular and cellular defects offers a promising therapeutic avenue for lung cancer.
  • Rational gene and cell-based therapies are under development.
  • Advancements in understanding lung cancer pathogenesis are crucial for improving patient outcomes.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer07:46

A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer

Published on: August 19, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...